Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients

Autor: Leal, Christianne Tolêdo de Souza, Costa, Luciano José Megale, Pereira, Juliana, Duarte, Fernando Barroso, Tavares, Raphael Barros, Atalla, Angelo, Sabioni, Bruna Sousa, Neto, Abrahão Elias Hallack
Zdroj: Bone Marrow Transplantation; February 2022, Vol. 57 Issue: 2 p309-311, 3p
Databáze: Supplemental Index
Externí odkaz: